18F-FCH-PET/MR in Staging of High-Risk Prostate Cancer: A Multiparametric Approach
This is a single centre, single arm feasibility study of 18FCH PET-MR imaging for staging
patients with high risk prostate cancer.
FCH-PET/MR will enable more accurate staging of patients with high risk prostate cancer as
compared to conventional imaging.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society